Andrew R Allen
CIK 1374539 · PRESIDENT AND CEO · last filed 2025-08-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
8
Total Filings
47
Lifetime Open-Market Net
-$11.93M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CGEM | Director | — | $13.70 | — | $0 | 1 | 2025-08-08 |
| Adaptimmune Therapeutics PLC (ADAP) Delisted | Director | — | $0.06 | — | $0 | 3 | 2024-07-01 |
| Gritstone bio, Inc. (GRTS) Delisted | PRESIDENT AND CEO | 1,310,360 | $0.03 | $42.2K | -$18.2K | 9 | 2024-06-26 |
| TCR2 THERAPEUTICS INC. (TCRR) Delisted | Director | — | $1.48 | — | $0 | 6 | 2023-06-01 |
| Sierra Oncology, Inc. (SRRA) Delisted | Director | 0 | $54.99 | $0 | $108.2K | 7 | 2022-07-01 |
| Epizyme, Inc. (EPZM) Delisted | Director | 20,560 | $1.47 | $30.2K | $0 | 8 | 2021-06-15 |
| Clovis Oncology, Inc. (CLVS) Delisted | See Remarks | 192,519 | $0.08 | $15.6K | -$12.02M | 8 | 2015-03-04 |
| PHARMION CORP (PHRM) Delisted | Chief Medical Officer, EVP | 1,005 | — | — | $0 | 4 | 2007-12-07 |
Recent Filings · Page 5 of 5
47 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2012-03-05 | Clovis Oncology, Inc. (CLVS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2011-11-21 | Clovis Oncology, Inc. (CLVS) Delisted | Mixed | +21,854 | $50.0K | EDGAR |
| 2008-03-12 | — | Mixed | −1,150 | $297.9K | |
| 2007-12-07 | PHARMION CORP (PHRM) Delisted | Mixed | +201 | $12.7K | EDGAR |
| 2007-12-07 | PHARMION CORP (PHRM) Delisted | Mixed | +145 | $9.3K | EDGAR |
| 2007-12-06 | PHARMION CORP (PHRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2007-11-16 | PHARMION CORP (PHRM) Delisted | Mixed | +804 | $33.0K | EDGAR |
Showing 41–47 of 47
Prev
Page 5 of 5
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.